Ceretec

Ceretec®

Imaging Technetium 99m–99mTc imaging agent commonly used with SPECT imaging to detect CVAs, which may be useful for diagnosing Alzheimer's disease. See Alzheimer's disease.
References in periodicals archive ?
Through this agreement, HealthTrust member facilities will have access to Life Sciences Core Imaging single-photon emission computed tomography (SPECT) proprietary products, such as Myoview, Ceretec, Indium-Oxine as well as non-GE Healthcare products, such as MDP, Indium In-111, Thallium chloride and Sodium Iodide 1-123 capsules.
His prior responsibilities include sales and marketing, commercial planning, product launch, healthcare economics, reimbursement, advocacy development, life cycle management, and business development for brands such as CERETEC, TAXUS, NATRECOR, RANEXA and OFIRMEV.
Although most of the company's manufacturing has been moved to its facility in Oslo, Norway, its Ceretec (technetium 99m exametazime) product cannot be produced in GE's other manufacturing sites because of production and regulatory issues.
According to GE's Web site, Ceretec helps demonstrate cerebral blood flow and visualize sites of infection through the labeling of white blood cells.
Tc-99m WBC scan with Ceretec (HMPAO) (GE Healthcare, Arlington Heights, IL)
Other evidence for CNS abnormalities in CFS comes from a recent study which analysed the brain perfusion of CFS patients and controls using Ceretec and single photon emission tomography (Costa, Brostoff, Douli & Ell, 1992).
As a result of this agreement, Syncor will distribute Ceretec, on a non-exclusive basis, for a two year period through its pharmacy network.
Its leadership in radiopharmaceuticals and brachytherapy is exemplified further by innovative products such as Ceretec (Technetium Tc-99m Exametazime Injection) used in brain imaging and in white blood cell labeling to detect infection and inflammation; Metastron
It is the leader in innovative products and services for nuclear medicine, and is the sole supplier of Ceretec (technetium 99m-exametazine injection), used for brain imaging and labeling white blood cells to detect infection and inflammatory processes; Metastron (strontium-89 chloride injection), a palliation therapy for bone cancer that has metastasized from other sites (usually prostate or breast cancer); I-125 Seeds and I-125 RAPID Strand (implantable devices for early-stage prostate cancer); and a number of other proprietary radiopharmaceuticals.
Ceretec and Metastron are the registered trademarks of Amersham International plc.